激酶锚定蛋白12在慢性肝病中的作用
DOI: 10.3969/j.issn.1001-5256.2023.03.037
利益冲突声明:所有作者均声明不存在利益冲突。
作者贡献声明:董海舰负责撰写论文;陶雨静、郭佳玲、钟宇汝、曾子键参与收集文献,修改论文;李晖负责拟定写作思路,指导文章撰写并最后定稿。
-
摘要: 激酶锚定蛋白(AKAP)12是一种支架蛋白,通过将细胞内信号蛋白组装成特定的复合体来提高时空信号的特异性和效率。近年来,AKAP12在慢性肝病中的作用越来越受到关注。本文介绍了AKAP12的生理功能,并对AKAP12在慢性肝病中的作用进行了总结,以期为AKAP12小分子作为新的慢性肝病治疗靶点研究奠定基础。
-
关键词:
- A型激酶锚定蛋白质类 /
- 肝硬化 /
- 非酒精性脂肪性肝病 /
- 肝疾病, 酒精性 /
- 癌, 肝细胞
Abstract: A-kinase anchor protein 12 (AKAP12) is a scaffold protein that improves the specificity and efficiency of spatio-temporal signals by assembling intracellular signal proteins into specific complexes. In recent years, the role of AKAP12 in chronic liver diseases has attracted more and more attention. This article introduces the physiological functions of AKAP12 and reviews the role of AKAP12 in chronic liver diseases, in order to lay a foundation for the use of AKAP12 small molecule as a new therapeutic target for chronic liver diseases. -
[1] QASIM H, MCCONNELL BK. AKAP12 signaling complex: impacts of compartmentalizing cAMP-dependent signaling pathways in the heart and various signaling systems[J]. J Am Heart Assoc, 2020, 9(13): e016615. DOI: 10.1161/JAHA.120.016615. [2] NAUERT JB, KLAUCK TM, LANGEBERG LK, et al. Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein[J]. Curr Biol, 1997, 7(1): 52-62. DOI: 10.1016/s0960-9822(06)00027-3. [3] MUKHERJEE M, RATNAYAKE I, JANGA M, et al. Notch signaling regulates Akap12 expression and primary cilia length during renal tubule morphogenesis[J]. FASEB J, 2020, 34(7): 9512-9530. DOI: 10.1096/fj.201902358RR. [4] NELSON PJ, GELMAN IH. Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response[J]. Mol Cell Biochem, 1997, 175(1-2): 233-241. DOI: 10.1023/a:1006836003758. [5] LIN X, GELMAN IH. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis[J]. Cancer Res, 1997, 57(11): 2304-2312. [6] KWON HB, CHOI YK, LIM JJ, et al. AKAP12 regulates vascular integrity in zebrafish[J]. Exp Mol Med, 2012, 44(3): 225-235. DOI: 10.3858/emm.2012.44.3.017. [7] TAKASE H, HAMANAKA G, OHTOMO R, et al. Roles of A-kinase anchor protein 12 in astrocyte and oligodendrocyte precursor cell in postnatal corpus callosum[J]. Stem Cell Rev Rep, 2021, 17(4): 1446-1455. DOI: 10.1007/s12015-021-10118-w. [8] LEE SW, KIM WJ, CHOI YK, et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier[J]. Nat Med, 2003, 9(7): 900-906. DOI: 10.1038/nm889. [9] CHOI YK, KIM KW. AKAP12 in astrocytes induces barrier functions in human endothelial cells through protein kinase Czeta[J]. FEBS J, 2008, 275(9): 2338-2353. DOI: 10.1111/j.1742-4658.2008.06387.x. [10] KHURANA A, SAYED N, ALLAWADHI P, et al. It's all about the spaces between cells: role of extracellular matrix in liver fibrosis[J]. Ann Transl Med, 2021, 9(8): 728. DOI: 10.21037/atm-20-2948. [11] WEISSMVLLER T, GLOVER LE, FENNIMORE B, et al. HIF-dependent regulation of AKAP12 (gravin) in the control of human vascular endothelial function[J]. FASEB J, 2014, 28(1): 256-264. DOI: 10.1096/fj.13-238741. [12] WU X, LUO Y, WANG S, et al. AKAP12 ameliorates liver injury via targeting PI3K/AKT/PCSK6 pathway[J]. Redox Biol, 2022, 53: 102328. DOI: 10.1016/j.redox.2022.102328. [13] LI Z, HU J, GUO J, et al. SSeCKS/Gravin/AKAP12 inhibits PKCζ-mediated reduction of ERK5 transactivation to prevent endotoxin-induced vascular dysfunction[J]. Cardiovasc Toxicol, 2019, 19(4): 372-381. DOI: 10.1007/s12012-018-09502-9. [14] BENZ PM, DING Y, STINGL H, et al. AKAP12 deficiency impairs VEGF-induced endothelial cell migration and sprouting[J]. Acta Physiol (Oxf), 2020, 228(1): e13325. DOI: 10.1111/apha.13325. [15] WALKER-GRAY R, KLUSSMANN E. The role of AKAP12 in coordination of VEGF-induced endothelial cell motility[J]. Acta Physiol (Oxf), 2020, 228(1): e13359. DOI: 10.1111/apha.13359. [16] YING HZ, CHEN Q, ZHANG WY, et al. PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review)[J]. Mol Med Rep, 2017, 16(6): 7879-7889. DOI: 10.3892/mmr.2017.7641. [17] DI SARIO A, BENDIA E, SVEGLIATI-BARONI G, et al. Rearrangement of the cytoskeletal network induced by platelet-derived growth factor in rat hepatic stellate cells: role of different intracellular signalling pathways[J]. J Hepatol, 2002, 36(2): 179-190. DOI: 10.1016/s0168-8278(01)00242-2. [18] YOU T, FAN Y, LI Q, et al. Increased SSeCKS expression in rat hepatic stellate cells upon activation in vitro and in vivo[J]. Inflammation, 2013, 36(6): 1415-1423. DOI: 10.1007/s10753-013-9681-4. [19] LEE HS, CHOI J, SON T, et al. A-kinase anchoring protein 12 is downregulated in human hepatocellular carcinoma and its deficiency in mice aggravates thioacetamide-induced liver injury[J]. Oncol Lett, 2018, 16(5): 5907-5915. DOI: 10.3892/ol.2018.9396. [20] LEE HS, CHOI J, SON T, et al. Altered AKAP12 expression in portal fibroblasts and liver sinusoids mediates transition from hepatic fibrogenesis to fibrosis resolution[J]. Exp Mol Med, 2018, 50(4): 1-13. DOI: 10.1038/s12276-018-0074-5. [21] BARNETT ME, MADGWICK DK, TAKEMOTO DJ. Protein kinase C as a stress sensor[J]. Cell Signal, 2007, 19(9): 1820-1829. DOI: 10.1016/j.cellsig.2007.05.014. [22] YANG JI, YOON JH, BANG YJ, et al. Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis[J]. Am J Physiol Gastrointest Liver Physiol, 2010, 298(1): G126-G132. DOI: 10.1152/ajpgi.00299.2009. [23] ZHANG LY, SHAO JG, XIAO F, et al. Mechanism of expression of the Src family kinases (Fgr, Hck, Lyn) and SSeCKS in non-alcoholic steatohepatitis[J]. Chin J Hepatol, 2015, 23(5): 363-367. DOI: 10.3760/cma.j.issn.1007-3418.2015.05.009.张玲燕, 邵建国, 肖锋, 等. Src家族相关激酶(Fgr, Hck, Lyn)/SSeCKS在非酒精性脂肪性肝炎中的作用机制[J]. 中华肝脏病杂志, 2015, 23(5): 363-367. DOI: 10.3760/cma.j.issn.1007-3418.2015.05.009. [24] FAN Q, YIN X, RABABA'H A, et al. Absence of gravin-mediated signaling inhibits development of high-fat diet-induced hyperlipidemia and atherosclerosis[J]. Am J Physiol Heart Circ Physiol, 2019, 317(4): H793-H810. DOI: 10.1152/ajpheart.00215.2019. [25] RAMANI K, TOMASI ML, BERLIND J, et al. Role of A-kinase anchoring protein phosphorylation in alcohol-induced liver injury and hepatic stellate cell activation[J]. Am J Pathol, 2018, 188(3): 640-655. DOI: 10.1016/j.ajpath.2017.11.017. [26] ZHANG J, PIAO HY, GUO S, et al. LINC00163 inhibits the invasion and metastasis of gastric cancer cells as a ceRNA by sponging miR-183 to regulate the expression of AKAP12[J]. Int J Clin Oncol, 2020, 25(4): 570-583. DOI: 10.1007/s10147-019-01604-w. [27] GELMAN IH. Emerging roles for SSeCKS/Gravin/AKAP12 in the control of cell proliferation, cancer malignancy, and barriergenesis[J]. Genes Cancer, 2010, 1(11): 1147-1156. DOI: 10.1177/1947601910392984. [28] HAN S, WANG L, SUN L, et al. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12[J]. Biomed Pharmacother, 2020, 122: 109754. DOI: 10.1016/j.biopha.2019.109754. [29] LAN X, WU N, WU L, et al. The human novel gene LNC-HC inhibits hepatocellular carcinoma cell proliferation by sequestering hsa-miR-183-5p[J]. Mol Ther Nucleic Acids, 2020, 20: 468-479. DOI: 10.1016/j.omtn.2020.03.008. [30] XIA W, NI J, ZHUANG J, et al. MiR-103 regulates hepatocellular carcinoma growth by targeting AKAP12[J]. Int J Biochem Cell Biol, 2016, 71: 1-11. DOI: 10.1016/j.biocel.2015.11.017. [31] YANG L, CAO J, WEI J, et al. Antiproliferative activity of berberine in HepG2 cells via inducing apoptosis and arresting cell cycle[J]. Food Funct, 2021, 12(23): 12115-12126. DOI: 10.1039/d1fo02783b.